Healthcare & Life Sciences
Libra Therapeutics
United Stateswww.libratherapeutics.com/
Libra Therapeutics is a series a startup based in United States. 1 investor tracked.
Activeseries-a
series-a
Stage
1
Investors
About Libra Therapeutics
Libra Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Libra Therapeutics develops novel disease-modifying therapeutics to restore cellular balance disrupted in neurodegenerative diseases by focusing on pharmacological activation of the lysosomal calcium ion channel, TRPML1, to increase autophagy and clear toxic proteins.
Explore Libra Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.